Fabrication of a Dual-Responsive Fluorescence Probe for Monitoring Cardiac Injury and Repairing by a Golgi-Targeting

Ao Li1, Zhe Chen1, Mengqi Wang1

  • 1School of Pharmacy, Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, 421001, P. R. China.

PubMed

Insights

A novel fluorescent probe (GHO) and hydrogen sulfide donor (GADT) target the Golgi apparatus to combat Doxorubicin-induced myocardial injury by reducing oxidative stress and promoting autophagy.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Molecular Biology

Background:

  • Doxorubicin (Dox) induces delayed myocardial injury via oxidative stress.
  • The Golgi apparatus plays a role in cardiovascular disease development.
  • Investigating Golgi stress is crucial for understanding Dox-induced cardiotoxicity.

Purpose of the Study:

  • Develop a dual-responsive fluorescent probe (GHO) for simultaneous detection of superoxide anion (O2•−) and peroxynitrite anion (ONOO−) in the Golgi apparatus.
  • Synthesize a Golgi-targeting hydrogen sulfide (H2S) donor (GADT) to intervene in Dox-induced cardiac damage.
  • Elucidate the mechanism of Golgi stress in Dox-induced myocardial injury.

Main Methods:

  • Development of a dual-emission fluorescent probe (GHO) for Golgi superoxide anion and peroxynitrite anion detection.
  • Synthesis of a Golgi-targeting hydrogen sulfide (H2S) donor (GADT).
  • Evaluation of GADT's antioxidant capacity and therapeutic effect in cardiomyocytes, zebrafish, and mice using the GHO probe.

Main Results:

  • The probe GHO successfully detected O2•− and ONOO− in the Golgi apparatus.
  • GADT demonstrated significant antioxidant capacity within the Golgi apparatus, mitigating Dox-induced reactive oxygen species (ROS).
  • GADT treatment recovered myocardial damage in various models and promoted the degradation of damaged Golgi apparatus via autophagy.

Conclusions:

  • The developed fluorescent probe GHO and Golgi-targeting H2S donor GADT offer a novel approach for studying and treating Dox-induced myocardial injury.
  • Targeting Golgi apparatus stress presents a promising therapeutic strategy for mitigating Doxorubicin cardiotoxicity.
  • The findings highlight the potential of autophagy in managing Dox-induced cardiac damage.